Welcome to our dedicated page for Clarivate Plc news (Ticker: CLVT), a resource for investors and traders seeking the latest updates and insights on Clarivate Plc stock.
Clarivate Plc (NYSE: CLVT) is described as a leading global provider of transformative intelligence, with news that reflects its activities across Academia & Government, Intellectual Property and Life Sciences & Healthcare. Company announcements frequently highlight new AI-powered tools, analytical reports and customer adoptions that illustrate how Clarivate combines enriched data, analytics and workflow software.
Recent news includes the launch of the Web of Science Research Assistant, a generative AI-powered tool that helps researchers conduct natural-language searches, perform literature reviews and explore visualizations based on more than 120 years of publication and citation data. Clarivate also reports on studies such as the Pulse of the Library report, which surveys thousands of librarians worldwide about AI adoption, open science and budget pressures, and on the annual Highly Cited Researchers list, which recognizes researchers whose work has had broad influence based on Web of Science data.
In Intellectual Property, Clarivate issues updates on solutions like IPfolio and Derwent Patent Monitor, including customer selections by organizations such as Nissan Motor Co., Ltd. and FUJIFILM Holdings Corporation. These stories emphasize how IP management platforms and AI-enabled patent review tools support more efficient IP operations and collaboration between IP and R&D teams.
Life sciences and healthcare news often centers on Clarivate analyses such as the Drugs to Watch report and Companies to Watch reports, which identify emerging therapies and innovative companies using integrated, AI-enhanced datasets. Visitors to this news page can follow Clarivate’s product launches, research reports, customer case studies and investor-related announcements to understand how the company is applying data and AI across its core markets.
Clarivate Plc (NYSE: CLVT) announced the 2022 list of Highly Cited Researchers, recognizing 6,938 researchers worldwide for significant contributions across various fields. The U.S. leads with 2,764 researchers but has seen a gradual decrease in share since 2018. Mainland China is rapidly closing the gap, now with 1,169 researchers. Clarivate has enhanced its analysis to prevent research misconduct, ensuring the list reflects genuine influence. Notable findings include 7,225 total awards across disciplines, highlighting the global diversity of research excellence.
On November 9, 2022, Clarivate Plc (NYSE: CLVT) announced that CEO Jonathan Gear and CFO Jonathan Collins will present at the RBC Capital Markets 2022 Technology, Internet, Media and Telecommunications Conference on November 15, 2022, at 1:25 PM Eastern Time. A live webcast of the presentation will be available here and can be replayed later. Clarivate specializes in information and insights to expedite innovation across various sectors.
On November 8, 2022, Clarivate Plc (NYSE: CLVT; CLVT PR A) declared a quarterly dividend of $1.3125 per share on its 5.25% Series A Mandatory Convertible Preferred Shares. This dividend is payable in cash on December 1, 2022 to shareholders recorded as of the close of business on November 15, 2022. Clarivate continues to affirm its commitment to delivering value to its shareholders through consistent dividend payments.
Clarivate reported Q3 2022 revenues of $635.7 million, marking a 43.8% increase, driven by the acquisition of ProQuest. However, a significant non-cash goodwill impairment led to a net loss of $4,434.4 million, with a net loss per share of $6.64. Organic revenue growth was 1.2%, with subscription revenues rising 65.6%, but transactional revenues declined 9.4%. Adjusted net income was $143.7 million, up 26.5%. The company generated $372.4 million in cash from operations.
Clarivate Plc (NYSE: CLVT) announced a settlement with OCLC regarding allegations of misconduct, which Clarivate firmly denies. The agreement emphasizes the importance of collaborative platforms for bibliographic records, with Clarivate agreeing to not develop a MARC records exchange system that conflicts with OCLC's policies. This settlement is aimed at supporting the goals of open research and data exchange, facilitating a more efficient research process. Clarivate will cover its own legal fees related to this settlement.
Newfold Digital has successfully acquired MarkMonitor™, an enterprise-level domain management provider, from Clarivate Plc (NYSE:CLVT) as of November 1, 2022. The acquisition enhances Newfold's capabilities in establishing and protecting online presence for businesses. CEO Sharon Rowlands emphasized MarkMonitor’s expertise and commitment to security, aiming for ongoing improvements in customer service. This is part of Newfold's strategy to expand its product offerings and enhance customer experience across its global operations.
On November 1, 2022, Clarivate Plc (NYSE:CLVT) announced the successful divestiture of MarkMonitor™ to Newfold Digital for $302.5 million. This strategic move allows Clarivate to concentrate on its core intellectual property portfolio. The net cash proceeds will aid in reducing outstanding debt, enhancing the company's financial position. The deal was previously announced on September 12, 2022, and aligns with Clarivate's mission to accelerate innovation through focused investments.
Clarivate Plc (CLVT) released a report highlighting that innovation in sustainable energy is declining, particularly in solar and wind power, which are nearing technical maturity. Although these energies have seen significant research over the last three decades, the report suggests that activity is slowing down. Oceanic power is still developing, showing potential but currently lacking maturity.
China leads in renewable energy innovation, outpacing the U.S. in patent activity. The study provides insights into research gaps and trends, aligning with global sustainability goals.
Clarivate Plc (NYSE:CLVT) has released a report titled RNA Technology Companies to Watch, highlighting seven innovative companies in the RNA technology space. These firms are addressing undruggable disease targets, demonstrating potential benefits such as fewer side effects and enhanced efficacy. The report notes a significant increase in RNA-related scientific research and patent filings, with the U.S. and Mainland China leading advancements. Despite challenges in RNA stability and delivery, the sector remains promising.
Clarivate Plc (NYSE:CLVT) published a report analyzing formal regional research assessment systems across Australia, Canada, Germany, Hong Kong, New Zealand, and the UK. The report indicates improvements in comparative research performance but lacks a consensus on whether research assessment is essential. Key insights include Australia's unique methodology, Canada's focus on knowledge mobilization, and the UK's historical role in establishing research assessment models. The report also highlights potential biases in AI-driven assessments and their implications for the research ecosystem.